These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4772875)

  • 1. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunological evaluation of the activity of total complement of the blood serum of patients with systemic lupus erythematosus].
    Zhuravlev GI; Rodshtein OA
    Ter Arkh; 1972 Nov; 44(11):29-33. PubMed ID: 4125143
    [No Abstract]   [Full Text] [Related]  

  • 3. Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells.
    Grevink ME; Horst G; Limburg PC; Kallenberg CG; Bijl M
    J Autoimmun; 2005 Jun; 24(4):329-36. PubMed ID: 15927794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I; Moravenik M; Diumenjo MS; Vannucci J
    Rev Clin Esp; 1977 Dec; 147(5):495-8. PubMed ID: 605255
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
    Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum complement determinations in patients with quiescent systemic lupus erythematosus.
    Sullivan KE; Wisnieski JJ; Winkelstein JA; Louie J; Sachs E; Choi R; Veksler E; Goldman D; Petri M
    J Rheumatol; 1996 Dec; 23(12):2063-7. PubMed ID: 8970042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunological evaluation of pleural effusions in systemic lupus erythematosus.
    Small P; Frank H; Kreisman H; Wolkove N
    Ann Allergy; 1982 Aug; 49(2):101-3. PubMed ID: 7103145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).
    Hurst NP; Nuki G; Wallington T
    Clin Exp Immunol; 1984 Feb; 55(2):303-12. PubMed ID: 6697566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus.
    Brandt L; Hedberg H
    Scand J Haematol; 1969; 6(5):348-53. PubMed ID: 4188539
    [No Abstract]   [Full Text] [Related]  

  • 13. Monocyte in vitro function in systemic lupus erythematosus (SLE). I. A clinical and immunological study.
    Svensson B
    Scand J Rheumatol Suppl; 1980; 31():29-41. PubMed ID: 6992266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum complement in systemic lupus erythematosus (SLE).
    Asano S; Marumo K; Igaki Y; Toyoizumi E; Okubo M
    Arerugi; 1968 Jul; 17(7):597-609. PubMed ID: 5726584
    [No Abstract]   [Full Text] [Related]  

  • 15. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus.
    Agnello V; De Bracco MM; Kunkel HG
    J Immunol; 1972 Mar; 108(3):837-40. PubMed ID: 4110990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activated complement in systemic lupus erythematosus].
    Porcel JM; Ordi J
    Med Clin (Barc); 1991 Feb; 96(4):135-7. PubMed ID: 2023487
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical importance of the complement system].
    Spath P; Huber H
    Wien Klin Wochenschr; 1973 Jun; 85(25):445-50. PubMed ID: 4123223
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus.
    Zurier RB
    Arthritis Rheum; 1976; 19(1):73-8. PubMed ID: 1252270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosus.
    Witte T; Dumoulin FL; Gessner JE; Schubert J; Götze O; Neumann C; Todd RF; Deicher H; Schmidt RE
    J Clin Invest; 1993 Sep; 92(3):1181-7. PubMed ID: 7690773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.